The Chem Ledger
Strategic Moves in Oncology, Construction, and EVs
Oncology Deals 1/ Merck & Co. has recently acquired Modifi Biosciences, a spinout from Yale University, for an upfront payment of $30 million. This acquisition also includes the potential for additional payments that could exceed $1.3 billion, depending on the success of the company's developments. Modifi Biosciences,